The company has successfully improved memory in mice through proof of concept trials and has received multiple small business innovation grants from the National Institutes of Health. They are currently focused on developing a device called 'Amytrapper' to trap amyloid from circulation, supported by a grant from NIA.
Organizations Involved
National Institutes of Health, Yale School of Medicine, Merck
Founders
Pazhani Sundaram
Company Description
Recombinant Technologies is an emerging biotechnology company.